urothelial carcinoma

Significant Breakthrough in Late-Stage Urothelial Carcinoma Treatment: ADC Combined with Immunotherapy Significantly Prolongs Survival

by

This study was led by Professor Guo Jun and Professor Sheng Xi Nan from Peking University Cancer Hospital, and the results have been published in the prestigious international journal The New England Journal of Medicine, and presented at the European Society for Medical Oncology (ESMO) conference. Core Efficacy Data: Significant Extension of Survival This study … Read more

Case Sharing | The Combination of Surgery, Radiotherapy, ADC, and Immunotherapy for High-Risk Invasive Urothelial Carcinoma

by
Case Sharing | The Combination of Surgery, Radiotherapy, ADC, and Immunotherapy for High-Risk Invasive Urothelial Carcinoma

Jing Yuming Professor Deputy Chief Physician of Urology at Xijing Hospital. Academic Positions: Member of the Minimally Invasive and Robotic Surgery Group of the Urology Branch of the Chinese Medical Doctor Association, Member of the Urology and Male Reproductive Association of the China Medical Healthcare International Exchange Promotion Association, Vice Chairman of the Minimally Invasive … Read more